carbidopa has been researched along with Day Blindness in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (40.00) | 18.7374 |
1990's | 1 (20.00) | 18.2507 |
2000's | 2 (40.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Acaroglu, G; Eryilmaz, T; Simsek, T | 1 |
Gould, TJ; Johnson, LN; Krohel, GB | 1 |
Guy, ME; Johnson, LN; Krohel, GB; Madsen, RW | 1 |
Duvoisin, RC | 1 |
Bodis-Wollner, I; Onofrj, M | 1 |
3 trial(s) available for carbidopa and Day Blindness
Article | Year |
---|---|
Efficacy of levodopa and carbidopa on visual function in patients with non-arteritic anterior ischaemic optic neuropathy.
Topics: Aged; Antiparkinson Agents; Carbidopa; Female; Humans; Levodopa; Male; Middle Aged; Optic Neuropathy, Ischemic; Prospective Studies; Treatment Outcome; Vision Disorders; Visual Acuity | 2005 |
Effect of levodopa and carbidopa on recovery of visual function in patients with nonarteritic anterior ischemic optic neuropathy of longer than six months' duration.
Topics: Aged; Aged, 80 and over; Arteritis; Carbidopa; Dopamine Agents; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Levodopa; Male; Middle Aged; Optic Neuropathy, Ischemic; Pilot Projects; Prospective Studies; Vision Disorders; Visual Acuity | 1996 |
Levodopa may improve vision loss in recent-onset, nonarteritic anterior ischemic optic neuropathy.
Topics: Aged; Arteritis; Carbidopa; Dopamine Agonists; Drug Combinations; Female; Humans; Levodopa; Male; Optic Neuropathy, Ischemic; Time Factors; Vision Disorders; Visual Acuity; Visual Fields | 2000 |
2 other study(ies) available for carbidopa and Day Blindness
Article | Year |
---|---|
Problems in the treatment of Parkinsonism.
Topics: Antiparkinson Agents; Arteriosclerosis; Carbidopa; Diagnosis, Differential; Drug Combinations; Eye Manifestations; Humans; Levodopa; Mental Disorders; Movement Disorders; Parasympatholytics; Paresthesia; Parkinson Disease; Vision Disorders | 1977 |
The visual system in Parkinson's disease.
Topics: Animals; Carbidopa; Drug Therapy, Combination; Evoked Potentials, Visual; Haplorhini; Humans; Levodopa; Parkinson Disease; Rats; Reaction Time; Vision Disorders; Vision Tests; Visual Acuity | 1987 |